Metipranolol side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Metipranolol. Common side effects include cardiac disorder among females, and circulatory collapse among males.
The phase IV clinical study is created by eHealthMe based on 82 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
82 people who take Metipranolol and have side effects are studied.
What is Metipranolol?
Metipranolol has active ingredients of metipranolol hydrochloride. Currently, eHealthMe is studying from 86 Metipranolol users.
Number of Metipranolol reports submitted per year:

Metipranolol side effects by gender *:
female:
- Cardiac disorder
- Application site irritation
- Atelectasis (partial or complete collapse of the lung)
- Atrioventricular block complete (heart block complete)
- Balance disorder
- Device expulsion
- Diarrhoea
- Disorientation (disability in which the senses of time, direction, and recognition of people and places)
- Drug ineffective
- Hypersensitivity
male:
- Circulatory collapse
- Cellulitis (infection under the skin)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Bacterial infection
- Blood bilirubin increased
- Body temperature increased
- Chest pain
- Coagulopathy (blood's ability to clot is impaired)
- Eye irritation
- Fall
Metipranolol side effects by age (0-1 to 60+) *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Device expulsion
30-39:
n/a
40-49:
- Angioneurotic oedema (swelling that occurs just beneath the surface of the skin or mucous membranes)
- Pulmonary embolism (blockage of the main artery of the lung)
- Angina pectoris (chest pain due to ischemia of the heart muscle)
- Blood bilirubin increased
50-59:
- Cellulitis (infection under the skin)
- Balance disorder
- Chest pain
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Petechiae (a small red or purple spot caused by bleeding into the skin)
60+:
- Circulatory collapse
- Mania (a state of abnormally elevated or irritable mood)
- Cardiac disorder
- Atelectasis (partial or complete collapse of the lung)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Atrioventricular block complete (heart block complete)
- Bacterial infection
- Body temperature increased
- Coagulopathy (blood's ability to clot is impaired)
- Diarrhoea
* Approximation only. Some reports may have incomplete information.
Do you take Metipranolol?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on metipranolol hydrochloride (the active ingredients of Metipranolol) and Metipranolol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Metipranolol:
- Metipranolol (86 reports)
All Metipranolol side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zaleplon and Proair Hfa drug interaction - 2 seconds ago
- Adcirca and Retinal Detachment - 3 seconds ago
- Citalopram Hydrobromide and Pomalidomide drug interaction - 20 seconds ago
- Monoket and Acute Kidney Failure - 24 seconds ago
- Monoket and Renal Failure - Acute - 24 seconds ago
- Fluconazole and Soxazole drug interaction - 31 seconds ago
- Depo-Provera and Rezulin drug interaction - 45 seconds ago
- Zomig and Ramipril drug interaction - 46 seconds ago
- Synthroid and Adverse Event - 48 seconds ago
- Imodium and Senna drug interaction - 51 seconds ago